ISAAC AMPOFO: Open Payments
NPI 1538640420 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 23 payments from 9 companies in 2025. Trend: 2023 $1,330 · 2024 $869 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| Alkermes, Inc. | 1 | $122 |
| Exact Sciences Corporation | 3 | $87 |
| Novo Nordisk Inc | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Amgen Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: LYBALVI, AIRSUPRA, Cologuard Collection Kit, BREZTRI, SHINGRIX, OTEZLA, ZORYVE, UNITHROID.
Industry payments across CT — which companies pay providers there.
